论文部分内容阅读
目的 :研究用 89Sr-氯化物治疗前列腺癌骨转移能否降低患者血清中粘附分子 E-选择素 (E- Selectin)水平。方法 :治疗组 2 5例均确诊为前列腺癌多发骨转移患者 ,其中 2 0例给予 89Sr-氯化物 (16 6 .6± 11.1MBq)治疗一次 ,其余 5例在首次治疗后 10个月再次给予相同剂量的 89Sr-
Objective: To study whether the treatment of prostate cancer with bone metastasis with 89Sr-chloride can reduce the serum adhesion molecule E-selectin (E-selectin) level. METHODS: Twenty-five patients in the treatment group were diagnosed with multiple bone metastases from prostate cancer. Twenty patients were treated with 89Sr-chloride (16 6.6 ± 11.1 MBq) once. The remaining 5 patients were given again 10 months after the first treatment. Same dose of 89Sr-